Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$2.5 - $5.19 $165,822 - $344,247
-66,329 Closed
0 $0
Q2 2021

Jul 20, 2021

SELL
$6.81 - $9.71 $269,410 - $384,137
-39,561 Reduced 37.36%
66,329 $551,000
Q4 2020

Jan 22, 2021

SELL
$10.34 - $13.77 $2.64 Million - $3.51 Million
-255,262 Reduced 70.68%
105,890 $1.15 Million
Q3 2020

Oct 19, 2020

BUY
$11.73 - $16.25 $1.13 Million - $1.56 Million
96,138 Added 36.28%
361,152 $4.31 Million
Q2 2020

Jul 23, 2020

BUY
$13.68 - $20.46 $651,687 - $974,673
47,638 Added 21.92%
265,014 $4.26 Million
Q1 2020

May 26, 2020

BUY
$14.83 - $26.72 $563 - $1,015
38 Added 0.02%
217,376 $5.23 Million
Q4 2019

Jan 21, 2020

BUY
$9.77 - $24.6 $1.03 Million - $2.6 Million
105,838 Added 94.92%
217,338 $5,000
Q3 2019

Oct 21, 2019

BUY
$10.17 - $13.86 $1.13 Million - $1.55 Million
111,500 New
111,500 $1,000

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Candriam S.C.A. Portfolio

Follow Candriam S.C.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

News

Stay updated on Candriam S.C.A. with notifications on news.